2019 - 2022 Development of a new treatment targeting RIP2 in inflammatory bowel diseases
2020 - 2021 Precision Medicine in Inflammatory Bowel Disease and Cancer
2018 - 2021 Analysis of tumor microimmune environment formed in the presence of liver cancer-induced HBx mutations
2018 - 2021 Effect of tyrosine kinase inhibitor for immunological microenviroment of hepatocellular carcinoma
2017 - 2020 Molecular link between stress response and cancer and its clinical implication
2016 - 2019 Development of innovative techniques of endoscopic ultrasound for early diagnosis of pancreatic cancer and its prognostic improvement
2015 - 2018 Development of biomarker for sorafenib treatment using serum microRNA in patients with hepatocellular carcinoma
2014 - 2017 Novel molecular target in colorectal cancer and inflammatory bowel disease
2013 - 2016 Ultrasound viscoelastography: development of quantitative imaging of tissue viscoelasticity based on fusion of static and dynamic tissue excitation
2013 - 2016 Technological development of endoscopic ultrasonography for improvement of diagnosis and prognosis of pancreatic diseases
2012 - 2015 Prediction of sorafenib response by FGF3 gene amplification for patients with hepatocellular carcinoma
2011 - 2013 Translational research focusing on the regulation of proteasome by Gankyrin
2010 - 2012 Moleculer mechanism of Hepatocarcinogenesis and Development : Combined Analysis with Kupffer phase Contrast-enchanced US and Gene Expression.
2010 - 2012 Development of systems with endoscopic ultrasonography for diagnosis and treatment of bilio-pancreatic diseases
2011 - 2011 Identification of sensitivity determinant factors of srafenib treatment in hepatocellular carcinoma.
2006 - 2008 Development of endosonography-guided puncture with biosensor and its application to evaluation of local pathophysiology in panereatic diseases
2006 - 2008 Newly Developed Image Analysis Method of Tumor Blood Flow : Separate Quantitative Analysis of Intranodular Arterial and Portal Blood Flow and Its Application to Research on Hepatocarcinogenesis
2004 - 2005 Hemodynamic and sinusoidal function change during multistep hepatocarcinogenesis : evaluation by contrast harmonic imaging
2003 - 2005 Evaluation of pancreatic microvasculature by contrast-enhanced endosonography with high resolution -application to diagnosis and treatment-
2002 - 2003 Imaging Analysis and Molecular Mechanism of angio architectural Change of the Tumor During Multistep Human Hepatocarcinogenesis
1998 - 2000 Molecular Mechanism and Blood Flow Imaging of the Formation of Angioarchitech titure during the Occurrence and Progression of Hepatocellular Carcinoma.
Show all
Papers (1,763)：
Andreas Teufel, Masatoshi Kudo, Yuquan Qian, Jimmy Daza, Isaac Rodriguez, Christoph Reissfelder, Ezequiel Ridruejo, Matthias P Ebert. Current Trends and Advancements in the Management of Hepatocellular Carcinoma. Digestive diseases (Basel, Switzerland). 2024
Margherita Rimini, Bernardo Stefanini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Fabian Finkelmeier, Changhoon Yoo, José Presa, Elisabeth Amadeo, et al. Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab. Liver international : official journal of the International Association for the Study of the Liver. 2024
Satoru Hagiwara, Toru Takase, Itsuki Oda, Yoriaki Komeda, Naoshi Nishida, Akihiro Yoshida, Tomoki Yamamoto, Takuya Matsubara, Masatoshi Kudo. Hereditary hemorrhagic telangiectasia with hepatic arteriovenous shunt diagnosed due to liver damage. Clinical Journal of Gastroenterology. 2024
Ken Kamata, Masatoshi Kudo, Tomohiro Watanabe. Indigo naturalis as a promising novel treatment for type 2 autoimmune pancreatitis. Pancreatology. 2024
Josep M Llovet, Roser Pinyol, Mark Yarchoan, Amit G Singal, Thomas U Marron, Myron Schwartz, Eli Pikarsky, Masatoshi Kudo, Richard S Finn. Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma. Nature reviews. Clinical oncology. 2024
Atezolizumab plus Bevacisumab versus lenvatinib for BCLC-B stage patients with hepatocellular carcinoma : a large real life worldwide population
(EASL Liver Cancer Summit 2024 2024)
